Ose Immunotherapeutics
Clinical trials sponsored by Ose Immunotherapeutics, explained in plain language.
-
New cancer drug combo shows promise in early trials
Disease control Recruiting nowThis early-stage study is testing a new immunotherapy drug called OSE-279, both alone and in combination with another drug, for people with advanced solid tumors or lymphomas. The trial aims to find safe doses and see if these treatments can help control cancer growth. It's speci…
Phase: PHASE1, PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New hope for lung cancer patients when first immunotherapy fails
Disease control Recruiting nowThis study is testing whether a new immunotherapy called OSE2101 works better than standard chemotherapy for people with advanced non-small cell lung cancer. It is for patients whose cancer initially responded to immunotherapy but then started growing again. About 363 participant…
Phase: PHASE3 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Mar 02, 2026 15:28 UTC